VIPR2 and inflammatory bowel disease: Intestinal sensory neurons release VIP, which directly engages VPAC2 receptors on Treg cells to induce PD‐1 expression and enhance suppressive activity, thereby suppressing autoimmune responses and offering potential therapeutic targets for inflammatory bowel disease (IBD) [81, 82].